# Trial of RAD001 and Neurocognition in Tuberous Sclerosis Complex (TSC)

> **NCT01289912** · PHASE2 · COMPLETED · sponsor: **Mustafa Sahin** · enrollment: 52 (actual)

## Conditions studied

- Tuberous Sclerosis Complex

## Interventions

- **DRUG:** RAD001
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01289912
- **Lead sponsor:** Mustafa Sahin
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-01
- **Primary completion:** 2014-12
- **Final completion:** 2014-12
- **Target enrollment:** 52 (ACTUAL)
- **Last updated:** 2018-01-25

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01289912

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01289912, "Trial of RAD001 and Neurocognition in Tuberous Sclerosis Complex (TSC)". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT01289912. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*